Varian Medical Systems (NYSE:VAR) SVP John W. Kuo sold 1,328 shares of the stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $125.51, for a total transaction of $166,677.28. Following the completion of the sale, the senior vice president now directly owns 30,708 shares in the company, valued at approximately $3,854,161.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
NYSE:VAR opened at $117.64 on Friday. The stock has a market capitalization of $10,998.94, a PE ratio of 32.68, a PEG ratio of 3.50 and a beta of 0.82. Varian Medical Systems has a fifty-two week low of $87.49 and a fifty-two week high of $130.29.
Varian Medical Systems (NYSE:VAR) last released its earnings results on Wednesday, January 24th. The medical equipment provider reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.06. Varian Medical Systems had a net margin of 4.27% and a return on equity of 27.13%. The company had revenue of $678.50 million during the quarter, compared to analysts’ expectations of $633.96 million. During the same period last year, the business earned $1.09 EPS. Varian Medical Systems’s revenue for the quarter was up 12.8% on a year-over-year basis. sell-side analysts predict that Varian Medical Systems will post 4.31 earnings per share for the current fiscal year.
Several brokerages have recently weighed in on VAR. Zacks Investment Research downgraded shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Wednesday, March 28th. ValuEngine raised shares of Varian Medical Systems from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. TheStreet downgraded shares of Varian Medical Systems from a “b+” rating to a “c” rating in a research note on Monday, February 12th. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research note on Sunday, January 28th. Finally, JPMorgan Chase raised their price target on shares of Varian Medical Systems from $88.00 to $105.00 and gave the stock a “neutral” rating in a research note on Thursday, January 25th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. Varian Medical Systems currently has an average rating of “Hold” and an average price target of $111.80.
Institutional investors and hedge funds have recently bought and sold shares of the business. WASHINGTON TRUST Co raised its position in Varian Medical Systems by 100.0% during the 4th quarter. WASHINGTON TRUST Co now owns 970 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 485 shares during the last quarter. Advisory Services Network LLC increased its holdings in shares of Varian Medical Systems by 3,418.8% during the 4th quarter. Advisory Services Network LLC now owns 1,689 shares of the medical equipment provider’s stock valued at $188,000 after purchasing an additional 1,641 shares in the last quarter. MUFG Americas Holdings Corp increased its holdings in shares of Varian Medical Systems by 45.2% during the 4th quarter. MUFG Americas Holdings Corp now owns 1,713 shares of the medical equipment provider’s stock valued at $190,000 after purchasing an additional 533 shares in the last quarter. Catawba Capital Management VA purchased a new position in shares of Varian Medical Systems during the 4th quarter valued at approximately $210,000. Finally, Ladenburg Thalmann Financial Services Inc. increased its holdings in shares of Varian Medical Systems by 27.7% during the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,968 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 427 shares in the last quarter. 99.21% of the stock is owned by institutional investors.
TRADEMARK VIOLATION WARNING: “Varian Medical Systems (NYSE:VAR) SVP Sells 1,328 Shares” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/08/varian-medical-systems-inc-var-svp-john-w-kuo-sells-1328-shares.html.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Varian Particle Therapy. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.